Jushi Holdings (JUSHF) Non-Current Assets (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Non-Current Assets of $352.6 million for Q2 2026, down 4.21% year-over-year from $368.1 million in Q2 2025, and up 0.62% quarter-over-quarter from $350.5 million in Q1 2026.
Jushi Holdings (JUSHF) Non-Current Assets (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Non-Current Assets for 6 consecutive years, with $352.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Non-Current Assets fell 4.21% year-over-year to $352.6 million; the TTM figure through Jun 2026 stood at $352.6 million (down 4.21% YoY), while the FY2025 annual figure was $354.0 million, down 3.84% from the prior year.
- Non-Current Assets grew to $352.6 million in Q2 2026 per JUSHF's latest filing, from $350.5 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $613.5 million in Q2 2022 and bottomed at $350.5 million in Q1 2026.
- Historically, Non-Current Assets has averaged $414.8 million across 5 years, with a median of $371.5 million in 2024.
- Annual changes were most pronounced in 2023 — Non-Current Assets slumped 32.97% — and 2025, when it gained 0.64%.
- Jushi Holdings' Non-Current Assets stood at $459.3 million in 2022, then retreated by 16.88% to $381.8 million in 2023, then dropped by 3.56% to $368.2 million in 2024, then retreated by 3.84% to $354.0 million in 2025, then dropped by 0.4% to $352.6 million in 2026.
- Business Quant data shows JUSHF's Non-Current Assets at $352.6 million in Q2 2026, $350.5 million in Q1 2026, and $354.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 2.96 Bn |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 352.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 352.63 Mn |
| Mar 31, 2026 | 350.46 Mn |
| Dec 31, 2025 | 354.03 Mn |
| Sep 30, 2025 | 363.10 Mn |
| Jun 30, 2025 | 368.14 Mn |
| Mar 31, 2025 | 364.97 Mn |
| Dec 31, 2024 | 368.17 Mn |
| Sep 30, 2024 | 360.79 Mn |
| Jun 30, 2024 | 366.45 Mn |
| Mar 31, 2024 | 374.85 Mn |
| Dec 31, 2023 | 381.76 Mn |
| Sep 30, 2023 | 400.41 Mn |
| Jun 30, 2023 | 411.20 Mn |
| Mar 31, 2023 | 454.94 Mn |
| Dec 31, 2022 | 459.29 Mn |
| Sep 30, 2022 | 584.54 Mn |
| Jun 30, 2022 | 613.49 Mn |
| Mar 31, 2022 | 536.92 Mn |
| Dec 31, 2021 | 497.69 Mn |